Non-invasive physical plasma for preventing radiation dermatitis in breast cancer: study protocol for a phase 3 randomised double-blind placebo-controlled trial (NIPP-RD III)

Radiation dermatitis (RD) is the most common side effect of breast irradiation, yet only few potent preventative and therapeutic options are available. Following encouraging results from a phase 1 and 2 trial on the topical use of non-invasive physical plasma (NIPP), a very well-tolerated physical t...

Full description

Bibliographic Details

Main Authors:	Dejonckheere, Cas S. (Author) , Layer, Julian Philipp (Author) , Sarria, Gustavo Renato (Author) , Wiegreffe, Shari (Author) , Glasmacher, Andrea Renate (Author) , Nour, Younèss (Author) , Scafa, Davide (Author) , Müdder, Thomas (Author) , Anzböck, Teresa (Author) , Giordano, Frank Anton (Author) , Stope, Matthias Bernhard (Author) , Schmeel, Leonard Christopher (Author) , Gkika, Eleni (Author)
Format:	Article (Journal)
Language:	English
Published:	19 March 2025
In:	Trials Year: 2025, Volume: 26, Pages: 1-10
ISSN:	1468-6694
DOI:	10.1186/s13063-025-08806-w
Online Access:	Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s13063-025-08806-w Verlag, kostenfrei, Volltext: https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-025-08806-w
Author Notes:	Cas Stefaan Dejonckheere, Julian Philipp Layer, Gustavo Renato Sarria, Shari Wiegreffe, Andrea Renate Glasmacher, Younèss Nour, Davide Scafa, Thomas Müdder, Teresa Anzböck, Frank Anton Giordano, Matthias Bernhard Stope, Leonard Christopher Schmeel and Eleni Gkika